Protocol Optimization

Medidata Protocol Optimization is an AI-powered solution designed to help clinical trial teams design smarter, more feasible studies before the first patient enrolls. By leveraging proprietary, cross-industry data and predictive modeling, it enables sponsors and research teams to evaluate planned protocols against real-world trial performance, identify inefficiencies early, and refine study design during the planning phase — reducing costly amendments and operational challenges down the line.

The platform addresses a core challenge in clinical development: protocol complexity and limited visibility into real-world performance make it difficult to balance scientific rigor with operational feasibility. Protocol Optimization bridges that gap by providing data-driven insights that inform smarter decision-making from the outset of study design.

Core Capabilities

• Activity-level metrics: Evaluate protocol performance at a granular level, including individual procedures and visit frequency, to understand their operational impact.
• Standardized, cross-industry trial data: Benchmark your protocol against one of the industry's largest datasets, comprising data from over 38,000 clinical trials and 12 million patients across multiple sponsors and indications globally.
• AI-powered predictive modeling: Use machine learning to simulate how specific design choices will affect key outcomes such as enrollment rates, dropout rates, timelines, and overall trial cost.
• Scenario planning: Run multiple design scenarios to compare the predicted impact of different protocol configurations, enabling teams to select the most operationally sound approach before finalizing the protocol.

Key Benefits

• Design with confidence: Use cross-industry benchmarks and predictive modeling to evaluate design choices early, balancing scientific rigor with operational execution from the start.
• Reduce risk early: Identify risk factors before the protocol is finalized by leveraging standardized, cross-sponsor data, significantly reducing the likelihood of costly protocol amendments later in the study lifecycle.
• Lower trial burden: Accurately quantify patient and site burden at the activity and visit level, identify likely cost drivers, and present leaner, less burdensome trials to sites — directly improving recruitment and retention outcomes.

Predictive Modeling and Simulation

• Forecast the impact of design elements such as procedures and visit frequency on enrollment rates, dropout rates, and study timelines.
• Transform site, patient, and indication-level data into clear, actionable scenarios tailored to your specific study.
• Proactively identify and mitigate risks before they affect trial performance or require protocol amendments.

Protocol Amendment Reduction

• Assess the operational feasibility of a protocol before it is finalized, reducing the need for amendments that are costly and disruptive later in the study lifecycle.
• Evaluate the operational impact of design changes up front using standardized, cross-sponsor data to surface risk factors early.

Medidata Protocol Optimization is part of the broader Medidata Platform, which encompasses Study, Patient, and Data experiences as well as Professional Services. Medidata also provides clients and partners with a range of training options, including self-paced and instructor-led courses, through its Global Education and Training program.